What are the next steps for a patient with abnormal sperm analysis results, including low progressive motility, abnormal morphology, and low viability?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Abnormal Sperm Analysis Results

Based on the provided sperm analysis results showing low progressive motility (34%), low viability (33%), and abnormal morphology (8%), the patient should undergo a complete male infertility evaluation by a urologist, including hormonal testing, physical examination, and potentially genetic testing.

Analysis of Current Sperm Parameters

The patient's semen analysis shows:

  • Volume: 1.5 mL (normal)
  • pH: 8 (normal)
  • Total motility: 40% (below normal threshold of 50%)
  • Progressive motility: 34% (below normal threshold)
  • Viability: 33% (significantly reduced)
  • Sperm count: 257.6 million/mL (normal)
  • Morphology: 8% (below normal threshold)
  • Increased viscosity (abnormal)

These results indicate asthenozoospermia (reduced motility) and teratozoospermia (abnormal morphology) with preserved sperm count (normozoospermia for concentration) 1.

Next Steps in Evaluation

1. Hormonal Evaluation

  • Perform endocrine evaluation including:
    • Serum testosterone
    • Follicle-stimulating hormone (FSH)
    • Additional hormones if indicated (LH, prolactin) 1, 2

2. Physical Examination

  • Complete genital examination focusing on:
    • Testicular size and consistency
    • Presence of varicocele (common reversible cause of abnormal parameters)
    • Examination of vas deferens and epididymis
    • Digital rectal examination 1, 2

3. Additional Testing

  • Consider genetic testing if severe asthenozoospermia persists, especially with:
    • Karyotype testing
    • Y-chromosome microdeletion testing 1, 2
  • Evaluate for oxidative stress and DNA fragmentation:
    • Sperm DNA fragmentation testing is justified as asthenozoospermia is associated with higher risk of DNA damage and oxidative stress 3

Treatment Approach

1. Address Reversible Causes

  • If varicocele is identified, consider varicocelectomy 2
  • If hormonal abnormalities are found, treat accordingly:
    • Consider selective estrogen receptor modulators (SERMs) like clomiphene citrate
    • Consider aromatase inhibitors if testosterone levels are low 2

2. Medical Therapy

  • Trial of antioxidant therapy:
    • Coenzyme Q10 may improve sperm motility
    • Consider combination antioxidant supplements 2, 3
  • Avoid testosterone monotherapy as it suppresses spermatogenesis 2

3. Assisted Reproductive Technology

  • If no improvement after 3-6 months of treatment:
    • Consider intrauterine insemination (IUI) as initial approach
    • For persistent severe abnormalities, in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) may be required 2

Important Considerations

  • Low sperm motility and abnormal morphology are associated with higher sperm DNA fragmentation, which can affect fertility outcomes 3, 4
  • The American Urological Association recommends a comprehensive evaluation when abnormal semen parameters are identified 1
  • Lifestyle modifications should be discussed:
    • Avoid excessive heat exposure to testes
    • Address obesity if present
    • Smoking cessation if applicable 1

Pitfalls to Avoid

  • Do not rely solely on a single abnormal semen analysis; confirm with repeat testing if borderline results are found 1
  • Avoid overlooking female partner factors; consider partner's age and fertility status when planning treatment 2
  • Do not delay referral to a reproductive specialist if parameters are significantly abnormal 1, 2

Remember that while these abnormal parameters indicate subfertility, they are not necessarily diagnostic of complete infertility, as there is considerable overlap between fertile and infertile men in semen parameters 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Male Infertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.